The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry

The RIETE Investigators

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)44-47
Number of pages4
JournalThrombosis Research
Volume218
DOIs
StatePublished - Oct 2022

Bibliographical note

Funding Information:
We express our gratitude to Sanofi Spain, LEO PHARMA and ROVI for supporting this Registry with an unrestricted educational grant. We also thank the RIETE Registry Coordinating Center, S&H Medical Science Service, for their quality control data, logistic and administrative support and Prof. Salvador Ortiz, Universidad Autónoma Madrid, Statistical Advisor in S&H Medical Science Service for the statistical analysis of the data presented in this paper.

Funding

We express our gratitude to Sanofi Spain, LEO PHARMA and ROVI for supporting this Registry with an unrestricted educational grant. We also thank the RIETE Registry Coordinating Center, S&H Medical Science Service, for their quality control data, logistic and administrative support and Prof. Salvador Ortiz, Universidad Autónoma Madrid, Statistical Advisor in S&H Medical Science Service for the statistical analysis of the data presented in this paper.

FundersFunder number
S&H Medical Science Service
Universidad Autónoma de Madrid

    Keywords

    • Anticoagulation
    • Antiplatelets
    • Direct oral anticoagulants
    • Venous thromboembolism
    • Vitamin K antagonists

    Cite this